JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M104873200 on September 26, 2001

J. Biol. Chem., Vol. 276, Issue 48, 45160-45167, November 30, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/48/45160    most recent
M104873200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winklhofer, K. F.
Right arrow Articles by Tatzelt, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winklhofer, K. F.
Right arrow Articles by Tatzelt, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Geldanamycin Restores a Defective Heat Shock Response in Vivo*

Konstanze F. WinklhoferDagger , Anja ReintjesDagger , Marius C. Hoener§, Richard Voellmy, and Jörg TatzeltDagger ||

From the Dagger  Department of Cellular Biochemistry, Max-Planck-Institut für Biochemie and the § Max-Planck-Institut für Neurobiologie, D-82152 Martinsried, Germany and the  Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, Miami, Florida 33101

Received for publication, May, 29, 2001, and in revised form, July 18, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Induced expression of heat shock proteins (Hsps) plays a central role in promoting cellular survival after environmental and physiological stress. We have previously shown that scrapie-infected mouse neuroblastoma (ScN2a) cells fail to induce the expression of Hsp72 and Hsp28 after various stress conditions. Here we present evidence that this impaired stress response is due to an altered regulation of HSF1 activity. Upon stress in ScN2a cells, HSF1 was converted into hyperphosphorylated trimers but failed to acquire transactivation competence. A kinetic analysis of HSF1 activation revealed that in ScN2a cells trimer formation after stress was efficient, but disassembly of trimers proceeded much faster than in the uninfected cell line. Geldanamycin, a Hsp90-binding drug, significantly delayed disassembly of HSF1 trimers after a heat shock and restored stress-induced expression of Hsp72 in ScN2a cells. Heat-induced Hsp72 expression required geldanamycin to be present; following removal of the drug ScN2a cells again lost their ability to mount a stress response. Thus, our studies show that a defective stress response can be pharmacologically restored and suggest that the HSF1 deactivation pathway may play an important role in the regulation of Hsp expression.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Stress response mechanisms are essential for the maintenance of cellular integrity and viability. Diverse stress conditions converge to enhance the synthesis of heat shock proteins (Hsps),1 many of which function as molecular chaperones in protein biosynthesis, folding, assembly, translocation, and degradation (1-6). In addition to preventing proteotoxic damage, Hsps also appear to be involved in antiapoptotic pathways (7-9). In animal models as well as in vertebrate cell culture models, overexpression of specific Hsps decreases cytotoxicity induced by different environmental stress conditions, including thermal and oxidative challenges, ischemia, or exposure to toxic chemicals (reviewed in Refs. 10-12).

In the nervous system, Hsps are thought to play an important role in a variety of pathophysiological states, including neurodegenerative diseases, cerebral ischemia, epilepsy, and trauma. Aged cells exhibit a decreased ability to induce Hsp72 in response to stress (13). This compromised induction of Hsp expression may reflect an adaptive cellular response. Aged cells and cells affected by age-related diseases (e.g. Alzheimer's disease, Huntington's disease, Parkinson's disease, and prion diseases) are characterized by an increased amount of abnormally folded proteins. If the stress response were functional in these cells, Hsp72 would be expressed permanently at high levels and may interfere with the apoptotic program and thereby with the elimination of diseased cells (14). Notably, the threshold for stress induction is significantly raised in cells exposed to a prolonged (moderate) stress (Ref. 15 and references therein).

At the molecular level, the different physiological and environmental stressors are integrated through the activation of a single transcription factor, the heat shock transcription factor 1 (HSF1). In unstressed mammalian cells, HSF1 exists in an inert nontrimeric form. In response to stress HSF1 assembles into homotrimers, binds to specific heat shock element (HSE) sequences present within inducible Hsp genes, and becomes hyperphosphorylated (reviewed in Refs. 16-19). Acquisition of HSE binding activity by trimer formation, however, is not sufficient to render HSF1 transactivation-competent (20-25), suggesting that factor activation occurs at least in two steps: trimerization and acquisition of DNA binding activity followed by induction of transcriptional competence. HSF1 trimer assembly is negatively regulated by the molecular chaperone Hsp90 (26-28) that may interact with the three hydrophobic repeat sequences of the transcription factor (29). Repression of the last step of HSF1 activation that ultimately leads to transactivation-competent factor appears to be mediated through a regulatory domain defined by Green et al. (30) and Zuo et al. (24). Although this final regulation step is not yet understood, it appears to involve chaperone interactions (28, 31, 32) as well as phosphorylation/dephosphorylation events (33-38).

Scrapie-infected mouse neuroblastoma (ScN2a) cells have proved useful to study certain aspects of prion diseases in cell culture. In contrast to uninfected N2a cells ScN2a cells propagate mouse prions and accumulate intracellular protein aggregates composed of proteinase K (PK)-resistant PrPSc. We previously reported that stress-induced expression of Hsp72 and Hsp28 is impaired in a ScN2a cell line, whereas uninfected N2a cells can mount an effective stress response (39). In this study, we show that HSF1 trimers formed in ScN2a cells after stress are rapidly disassembled and lack transactivation competence. We demonstrate that the Hsp90-binding drug geldanamycin corrects the defective regulation of HSF1 activity after heat stress in ScN2a cells.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Recombinant Plasmid DNAs-- Expression constructs for wtHSF1, Delta HSF1, HSE-Luc, beta -galactosidase, and GRE-Luc were described previously (24, 40, 41). The luciferase reporter vector pGL3 control was purchased from Promega.

Antibodies-- Polyclonal anti-PrP antiserum A4 was raised against recombinant full-length PrP that was expressed and purified from bacteria (42). The mouse monoclonal antibody specific for inducible Hsp72 (C92) has been characterized previously (43). The mouse monoclonal antibody N27 (clone N27F3-4) that identifies both the inducible and the constitutive form of Hsp70, the rabbit polyclonal antibody against Hsp90 (clone 2D12), and the mouse monoclonal antibody against Hsp90 (clone AC88) were purchased from StressGen, and the mouse monoclonal antibody specific for p23 (clone JJ3) was purchased from Affinity Bioreagents.

Cell Culture-- N2a and ScN2a cells were grown in minimum essential Eagle's medium supplemented with antibiotics (1 unit/ml penicillin G and 1 mg/ml streptomycin) and 10% fetal calf serum. N2a cells are an immortalized neuroblastoma cell line (ATCC number CCl 131). ScN2a cells were established by infecting N2a cells with an enriched preparation of prions isolated from the brains of scrapie-infected mice.

Transfections-- One day before transfection, the cells were plated at a density of 1 × 106 cells/35-mm plate in supplemented medium. The cells were transfected by a liposome-mediated method using LipofectAMINE PlusTM Reagent (Life Technologies, Inc.). In brief, 1 µg of plasmid DNA was precomplexed with 6 µl of Plus Reagent in 100 µl of Optimem (Life Technologies, Inc.) at room temperature for 15 min. 8 µl of LipofectAMINE in 100 µl of Optimen were added and incubated for another period of 15 min. After adding 800 µl of Optimem, the DNA-liposome-Optimem mixture was poured onto the rinsed cells. After incubation of cells at 37 °C for 3 h, 1 ml of supplemented medium was added.

Stress Treatment-- For a heat shock cell culture, dishes were placed in a water bath for the time and temperature indicated. Geldanamycin was dissolved in Me2SO, added to the cells 2 h prior to a heat shock, and removed after 3 h. The controls were treated with Me2SO alone.

Detergent Solubility Assay-- As described by Tatzelt et al. (44), the cells were washed twice with cold phosphate-buffered saline (PBS), scraped from the plate, pelleted by centrifugation, and lysed in cold buffer A (0.5% Triton X-100 and 0.5% sodium deoxycholate in PBS). The lysate was centrifuged at 15,000 × g for 20 min at 4 °C; the supernatants and pellets were examined by immunoblotting.

Proteolysis Experiments-- N2a and ScN2a cells were lysed as described above. To the lysate (50 µg of total protein) proteinase K (1 µg) was added, and the samples were incubated at 30 °C for 30 min. The reaction was terminated by the addition of Pefabloc SC (Roche Molecular Biochemicals) and boiling in Laemmli sample buffer. Residual PrP was detected by Western blotting.

Western Blot Analysis-- Detergent-fractionated cell lysates were size fractionated by SDS-polyacrylamide gel electrophoresis, and the proteins were transferred to nitrocellulose (Protran BA 85, Schleicher & Schüll) by electroblotting. The nitrocellulose membranes were blocked with 5% nonfat dry milk in PBST (PBS containing 0.1% Tween 20) for 30 min at room temperature and subsequently incubated with primary antibody in PBST for 16 h at 4 °C. After extensive washing with PBST, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody for 40 min at room temperature. Following washing with PBST, the antigen was detected with the enhanced chemoluminescence detection system (Amersham Pharmacia Biotech) as specified by the manufacturer.

Luciferase and beta -Galactosidase Assays-- 1 µg of reporter plasmid (HSE-Luc or GRE-Luc) was transfected into N2a and ScN2a cells. 24 h after transfection, the cells were heat shocked (HSE-Luc) or incubated with dexamethasone (10 nM; Sigma) (GRE-Luc) and further incubated at 37 °C for 16 h cells. Luciferase activity of cell lysates was determined luminometrically by a luciferase assay system (Promega) as specified by the manufacturer. For the analysis of Delta HSF-induced activation, the reporter plasmid HSE-luc was co-transfected with 1 µg of effector plasmid coding for Delta HSE. 48 h after transfection the cells were assayed for luciferase activity. Transfection efficiencies were normalized by co-transfection of a plasmid expressing beta -galactosidase under control of a cytomegalovirus promoter. beta -Galactosidase activity was determined spectrophotometrically by a beta -galactosidase enzyme assay system (Promega). All transfections were performed repeatedly and in triplicate.

Northern Blot Analysis-- Cytosolic RNA was isolated using a commercially available kit (RNeasy mini kit; Qiagen). For each sample, 5 µg of cytoplasmatic RNA were separated electrophoretically on a 1% agarose/formaldehyde gel, transferred to a positively charged nylon membrane (Hybond N+; Amersham Pharmacia Biotech), and cross-linked by UV irradiation. For hybridization the nylon membranes were prehybridized in hybridization buffer (5× SSC, 10× Denhardt's solution, 50% formamide, 1% SDS, 1% bovine serum albumin, 200 mg/ml denaturated salmon sperm DNA) at 45 °C for 2 h, followed by an incubation in hybridization buffer with a probe containing the 32P-labeled DNA probe specific for Hsp72 (45) or mouse PrP overnight at 45 °C. The probe was prepared by using the random primed DNA synthesis (oligolabeling kit; Amersham Pharmacia Biotech) in the presence of [alpha -32P]dCTP (3000 Ci/mmol; Amersham Pharmacia Biotech). After washing with 2× SSC, 1% SDS and 0.2× SSC, 1% SDS for several times at 50 °C, hybridization signals were detected by autoradiography.

Electrophoretic Mobility Shift Assays-- Preparation of cell extracts and gel shift assays were performed as previously described by Baler et al. (46). Whole cell extracts were prepared by freezing pellets of PBS-washed cells in liquid nitrogen. After thawing the pellet was resuspended in two packed cell volumes of buffer C (20 mM HEPES, pH 7.9, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 10 µg leupeptin/ml, 0.01 unit aprotinin/ml, 25% glycerol, 0.1% Igepal CA-630; Sigma), and the concentration of NaCl was adjusted to 0.38 M. After 10 min of incubation on ice, the extract was centrifuged at 4 °C for 15 min at 10,000 × g. For the binding reaction 20 µg of protein was added to 10 µl of 2× Kingston buffer (24 mM HEPES, pH 7.9, 120 mM KCl, 4 mM MgCl2, 0.24 mM EDTA, 0.6 mM phenylmethylsulfonyl fluoride, 0.6 mM dithiothreitol, and 24% glycerol), 1 µl of sonicated salmon sperm DNA (1 mg/ml), 1 µl of poly(dI-dC) (1 mg/ml), and 1.75 pmol of 32P-labeled, double-stranded HSE oligonucleotide (47). The final volume of the mixture was adjusted to 20 µl with water. Double-stranded HSE oligonucleotides were end-labeled with [gamma -32P]ATP (3000 Ci/mmol; Amersham Pharmacia Biotech) and T4 polynucleotide kinase (Promega) and purified on a Micro Bio-Spin 30 column (Bio-Rad). Following binding at room temperature for 20 min the mixtures were loaded onto nondenaturing 4% polyacrylamide gel in 0.5 TBE (45 mM Tris borate, 1 mM EDTA). Gels were electrophoresed for 2.5 h at 150 V, dried, and exposed for autoradiography.

Indirect Immunofluorescence-- N2a and ScN2a cells were grown on glass coverslips and fixed by immersion in cold methanol for 10 min. The fixed cells were incubated with the anti-Hsp72 antibody C92 (dilution of 1:50) or with the monoclonal anti-Hsp90 antibody (dilution of 1:100) in PBS containing 1% bovine serum albumin for 45 min at 37 °C. After extensive washing with PBS, an incubation with rhodamine-conjugated anti-mouse antibodies (Dianova) (dilution 1:200) followed at 37 °C for 30 min. The washed coverslips were mounted onto glass slides and examined by phase contrast and fluorescence microscopy.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Scrapie-infected N2a Cells Do Not Express Inducible Hsp72 and Hsp28 after Heat Shock-- ScN2a cells provide a system to study the accumulation of infectious PrPSc in cell culture (48-50). In addition to productive propagation of detergent insoluble, PK-resistant, and infectious PrPSc, the same cells were described by us to be impaired in the stress-induced expression of Hsp72 and Hsp28 (39). It is important to note that the deregulated stress response in ScN2a cells was restricted to the two most highly inducible stress proteins Hsp72 and Hsp28; exposure of ScN2a cells to various stress conditions resulted in increased expression of Hsp73, Hsp90, grp75, grp78(BiP), and grp94, as determined by two-dimensional gel electrophoresis (see Fig. 2 in Ref. 39). The deregulated expression of Hsp72 in ScN2a cells is again illustrated by the experiment shown in Fig. 1. Three independently established ScN2a cell lines were analyzed with respect to propagation of PrPSc and expression of Hsp72 subsequent to heat treatment. In contrast to uninfected N2a cells, all of the three ScN2a cell lines harbored significant amounts of detergent-insoluble (Fig. 1A, - PK) and PK-resistant PrPSc (Fig. 1A, PK). After thermal challenge (44 °C, 20 min), only N2a cells but none of the ScN2a cell lines expressed inducible Hsp72 (Fig. 1A, alpha -Hsp72) and Hsp28 (data not shown). Thus, at least three different ScN2a cell lines showed defective expression of the two inducible stress proteins Hsp72 and Hsp28.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 1.   Three different ScN2a cell lines lack a functional heat shock response. A, monolayer N2a and ScN2a cells of three independently established cell lines (ScN2a, I-III) were solubilized in cold buffer A (0.5% Triton X-100 and 0.5% sodium deoxycholate in PBS). The lysates were mock-incubated (- PK) or incubated with proteinase K (PK) and centrifuged to obtain the detergent soluble (Supernatant) and insoluble (Pellet) protein fraction. PrP present in each fraction was detected in immunoblotting experiments using the anti-PrP antibody A4 (alpha -PrP). Expression of the heat-inducible Hsp72 was analyzed in protein lysates prepared from N2a and ScN2a I-III cells after exposure to heat (44 °C, 20 min) and subsequent cultivation at 37 °C for 16 h using the anti-Hsp72 antibody C92 (alpha -hsp72). B, N2a and ScN2a I cells were lysed by boiling in Laemmli sample buffer, and equal amounts of protein were analyzed by Western blotting using antibodies against Hsp73, Hsp90, and p23.

To rule out that expression levels of proteins that are involved in the regulation of HSF1 activity were different in N2a and ScN2a cells, we performed a Western blot analysis with antibodies against Hsp73, Hsp90, and p23. As shown in Fig. 1B, no obvious differences could be detected in the relative amounts of the respective proteins. This analysis also indicated that in ScN2a cells the apparent lack of Hsp72 expression after stress is not accompanied by increased constitutive levels of Hsp73, which could compensate for the impaired Hsp72 expression. The following experiments, which attempt to analyze the underlying mechanism, were carried out using ScN2a cell line I.

Activation of an Exogenous Hsp72 Promoter by Thermal Challenge Is Impaired in ScN2a Cells-- We have previously shown that trimeric, hyperphosphorylated HSF1 formed in heat-shocked ScN2a cells failed to transactivate the major Hsp72 gene (39). To test the possibility that a defect in the endogenous Hsp72 gene was responsible for the absence of induced Hsp72 expression, we performed transient transfection experiments with a DNA construct (HSE-Luc) expressing firefly luciferase under the control of the highly heat-inducible promoter of the human Hsp70B gene (40). Transfected cells were subjected to heat for different periods of time and analyzed for luciferase activity. In N2a cells, luciferase activity increased greatly after heat shock. Levels attained were proportional to the duration of the thermal challenge. In ScN2a cells, luciferase activities were significantly lower than in N2a cells under all heat shock conditions tested (Fig. 2A). Initially, we were puzzled about the activation of HSE-Luc in ScN2a cells, especially under more severe heat shock conditions. This activation was most likely due to the presence of trimeric HSF1 that lacks the competence to transactivate the endogenous Hsp72 promoter but induces a weak transcription from the transfected HSE-Luc construct. Support for this notion was derived from experiments in which N2a and ScN2a cells were co-transfected with HSE-Luc and an expression construct for either wild type (wt)HSF1 or a HSF1 mutant denoted Delta HSF. Delta HSF contains a deletion in the regulatory domain (Delta 202-316) and is constitutively active (24). Co-transfection of HSE-Luc and wtHSF resulted in weak activation of HSE-Luc in both N2 and ScN2a cells (Fig. 2B, wtHSF). The luciferase activity in wtHSF-expressing ScN2a cells was comparable with the activity in ScN2a cells subjected to a severe heat shock (Fig. 2A). Of note, overexpression of wtHSF generates trimeric HSF1, which, however, is not sufficient to induce expression from the endogenous Hsp72 promoter (Fig. 3B). We therefore concluded that the weak activation of HSE-Luc in ScN2a cells after a severe heat shock resulted from trimeric HSF1, which is incompetent to transactivate the endogenous Hsp72 promoter. Indeed, HSF1 trimers were generated in ScN2a cells after a heat stress, as determined by electrophoretic mobility shift assays (see Fig. 5A).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Activation of an exogenous HSE promoter by heat and Delta HSF. A and C, N2a and ScN2a cells were transiently co-transfected with a reporter plasmid encoding luciferase under the control of a HSE promoter (HSE-Luc) and a plasmid encoding beta -galactosidase under the control of a cytomegalovirus promoter. 24 h after transfection, the cells were subjected to a heat shock (44 °C) for the time indicated, returned to 37 °C, and harvested after additional 16 h. A, luciferase activity in the cell extracts was quantified as described under "Experimental Procedures." Luciferase activity in cells cultivated constantly at 37 °C was set as 1. B, N2a and ScN2a cells were transiently co-transfected with HSE-luc and a plasmid encoding either wtHSF1 or a constitutively active HSF1 mutant (Delta HSF) under the control of a cytomegalovirus promoter. After transfection cells were cultivated at 37 °C for 24 h; luciferase activity was measured and graphically presented as described for A. C, beta -galactosidase activity in the same extracts as shown for A was quantified as described under "Experimental Procedures." D, N2a and ScN2a cells were transfected with a plasmid coding for luciferase under the control of a constitutive SV40 promoter and treated in parallel exactly like the cells analyzed for A. All graphs represent the quantitative analysis of at least three independently conducted experiments.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   Geldanamycin restores the stress response in ScN2a cells. N2a and ScN2a cells were grown on glass coverslips, and expression of Hsp72 was determined by indirect immunofluorescence using the anti-Hsp72 antibody C92. A, cells were cultivated at 37 °C (37 °C), subjected to 44 °C for 20 min (44 °C), subjected to geldanamycin (5 µM, 3 h) (GA), or subjected to a heat shock 2 h after administration of GA (GA + 44 °C). Subsequent to the stress treatment, the cells were further cultivated in fresh cell culture medium and analyzed after an additional 16 h at 37 °C. B, ScN2a cells grown on glass coverslips were transfected with a plasmid encoding wtHSF1 or the constitutively active Delta HSF1 mutant (Delta HSF). Expression of Hsp72 was analyzed by indirect immunofluorescence of cells grown at 37 °C (37 °C) or subjected to 44 °C for 20 min (44 °C) as described for A. C, N2a and ScN2a cells were incubated with or without GA (5 µM, 3 h). The expression pattern of Hsp90 was analyzed by indirect immunofluorescence. D, N2a and ScN2a cells were transfected with GRE-Luc and incubated with dexamethasone (10 nM for 16 h. Then luciferase activity of cell lysates was quantified luminometrically.

Co-transfection of the Delta HSF construct with HSE-Luc resulted in an extremely high luciferase activity in N2a and ScN2a cells even without applying a heat shock. (Fig. 2B, Delta HSF), Notably, overexpression of Delta HSF was sufficient to induce expression of Hsp72 in ScN2a cells (Fig. 3B). To verify that the different levels of luciferase activity measured in our stress activation assay reflected stress-regulated promoter activity and not differences in transfection efficiencies or instability of luciferase, two different control experiments were performed. In the analysis shown in Fig. 2C, a plasmid encoding beta -galactosidase under control of a cytomegalovirus promoter was co-transfected. Similar levels of beta -galactosidase in N2a and ScN2a cells indicated similar transfection efficiencies. In addition, N2a and ScN2a cells were transfected in parallel with a plasmid coding for luciferase under the control of a constitutive SV40 promoter and treated exactly like the cells analyzed in Fig. 2A. The results of this experiment demonstrated that activity of luciferase was not different in the ScN2a background (Fig. 2D).

In conclusion, these experiments indicated that ScN2a cells are significantly impaired to induce expression from Hsp promoters using their own HSF1. It appears therefore that the virtual inability of ScN2a cells to induce expression of Hsp72 and Hsp28 during stress is caused by a defect in the activation of endogenous HSF1.

Geldanamycin Restores the Deregulated Heat Shock Response in ScN2a Cells-- To get insight into the regulation of HSF1 activity in ScN2a cells, we tried to modulate the heat shock response pharmacologically. Geldanamycin, a benzoquinone ansamycin, interacts with Hsp90 and interferes with Hsp90-dependent signal transduction pathways (51-59). Recently, Hsp90 has been described to be involved in the negative regulation of HSF1 activity (26-28). Consequently, we examined the effect of geldanamycin on the expression of Hsp72 in N2a and ScN2a cells. The cells were grown on glass coverslips at 37 °C and then subjected to treatment by heat (44 °C for 20 min), geldanamycin (5 µM for 3 h), or both. In the latter case the heat shock was applied 2 h after geldanamycin was added. After further incubation at 37 °C for 16 h in fresh medium, expression of Hsp72 was detected by indirect immunofluorescence. The results showed that after thermal stimulation the entire population of N2a cells expressed Hsp72, whereas no ScN2a cell stained positive for Hsp72 under the same conditions. Interestingly, in N2a cells the effect of geldanamycin on the expression of Hsp72 was restricted to a small subpopulation of cells (Fig. 3A, N2a, GA). A similar discrete pattern of Hsp72 expression was detected in ScN2a cells subjected to combined thermal and geldanamycin treatment (Fig. 3A, ScN2a, GA + 44 °C). This restricted expression of Hsp72 might reflect a cell cycle-dependent action of geldanamycin, which has been shown to interfere with the expression of different cyclins (60-63). Unfortunately, it was not possibly to verify this speculation because the ScN2a cells did not survive geldanamycin and heat treatment after synchronization. In summary, the ScN2a cell line was found to be a homogenous population with respect to the impaired stress response. Heat stress-inducible expression of Hsp72 could be restored by short term incubation of cells with the Hsp90-binding drug geldanamycin. Expression analysis indicated that the relative amount of Hsp90 was similar in N2a and ScN2a cells. (Fig. 1B). To investigate possible differences in the subcellular localization of Hsp90, we performed indirect immunofluorescence experiments. In N2a cells a diffuse cytosolic Hsp90 staining was observed, and we could not find differences between untreated and geldanamycin-treated N2a cells (Fig. 3C, N2a). In ScN2a cells, however, Hsp90 distribution was predominantly inhomogenous, reminiscent of aggresomal compartmentalization. Interestingly, after geldanamycin treatment this discrete pattern of accumulated Hsp90 disappeared, now resembling the uniform pattern found in N2a cells (Fig. 3C, ScN2a). Notably, in this experiment geldanamycin was used in the same concentration that restored the stress-induced expression of Hsp72. Additional proof of an impaired function of Hsp90 in ScN2a cells was obtained by analyzing the activation pathway of the glucocorticoid receptor, which is regulated similarly to HSF1 (65). After transfection of a GRE-Luc reporter construct, stimulation of the endogenous glucocorticoid receptor by dexamethasone resulted in a more than 55-fold luciferase activity in N2a cells, whereas in ScN2a cells luciferase activity was increased only 9-fold (Fig. 3D). Of note, there were no differences in the levels of endogenous glucocorticoid receptor between the two cell lines (data not shown).

Overexpression of Delta HSF and wtHSF Overcomes the Impaired Activation of Endogenous HSF1 in ScN2a Cells-- The experiments described above supported the hypothesis that HSF1 regulation is defective in ScN2a cells. Moreover, they showed that the defect could be corrected by exposure to geldanamycin. To further probe the defect in the stress response in ScN2a cells, we transiently transfected expression constructs for either constitutively active Delta HSF or wtHSF1. Hsp72 expression was detected by indirect immunofluorescence in unstressed cells or in cells exposed to a heat shock (44 °C for 20 min). In agreement with the co-transfection experiments discussed before, ScN2a cells transfected with the Delta HSF construct expressed Hsp72 without stress (Fig. 3B, Delta HSF, 37 °C). Note that in this case the nonuniform pattern of Hsp72-positive cells reflected transfection efficiency, which was verified by co-transfection of a plasmid expressing green fluorescent protein (data not shown). After a heat shock, no further increase in Hsp72-positive cells was seen, corroborating our previous results that untransfected ScN2a cells could not mount a heat shock response. No Hsp72 expression was observed in unstressed ScN2a cells overexpressing exogenous wild type HSF1 (Fig. 3B, wt HSF, 37 °C), even though overexpressed wild type HSF1 was largely present as trimers (data not shown). In contrast, a moderate level of Hsp72 expression was observed in HSF1-overexpressing ScN2a cells that had been heat-treated (Fig. 3B, wt HSF, 44 °C). Taken together, we have established three ways of inducing Hsp72 expression in ScN2a cells. Overexpression of Delta HSF resulted in a stress-independent expression of Hsp72, and overexpression of wtHSF1 or treatment with the Hsp90-binding drug geldanamycin restored the heat stress inducibility of Hsp72 expression.

Geldanamycin Delays Disassembly of HSF1 Trimers after Heat Shock-- To determine the mechanism by which geldanamycin restores the defective heat response, we analyzed transcription of the Hsp72-specific mRNA by Northern blotting. In N2a cells pretreatment with geldanamycin significantly prolonged Hsp72 transcription after a heat shock (Fig. 4A). After heat shock Hsp72-specific mRNA rapidly appeared in the cytosol and could be detected for about 2 h. (Fig. 4A, hs). If geldanamycin was applied 2 h prior to the heat shock, Hsp72-specific mRNA could now be detected for up to 8 h after the thermal stimulus (Fig. 4A, hs + GA). In ScN2a cells neither heat shock nor geldanamycin alone was sufficient to induce transcription; however, a combination of both stimuli resulted in the appearance of Hsp72-specific mRNA (Fig. 4B, hs + and GA +), corroborating our analysis of Hsp72 expression by immunofluorescence (Fig. 3A, ScN2a, GA + 44 °C). Thus, the Northern blot analysis was consistent with the results on the expression of Hsp72 obtained by immunofluorescence and indicated that geldanamycin prolonged transcription of Hsp72-specific mRNA in heat-treated N2a cells.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 4.   Geldanamycin induces expression of Hsp72-specific mRNA in ScN2a cells. A, N2a cells were subjected to 44 °C for 20 min (hs) or incubated with geldanamycin (5 µM, 3 h) 2 h prior to the heat shock (hs + GA) and returned to 37 °C. At the time points indicated cytosolic RNA was isolated and probed for Hsp72-specific (hsp72) and PrP-specific (PrP) mRNA by Northern blotting. B, ScN2a cells were analyzed in parallel as described for N2a cells for A. Cytosolic RNA was isolated 2 h after the heat shock. At later time points no Hsp72-specific mRNA was detectable (data not shown).

We next examined HSF1 trimerization and trimer disassembly in N2a and ScN2a cells exposed to a heat shock in the presence or absence of geldanamycin. The electrophoretic mobility shift assay is based on the HSE binding activity specific for HSF1 trimers. We had previously shown that the relative levels of HSF1 and the formation of hyperphosphorylated HSF1 trimers after stress was comparable in N2a and ScN2a cells (see Fig. 3 in Ref. 39). To extend these earlier studies, N2a and ScN2a cells were treated at 44 °C for 20 min, returned to 37 °C, and examined thereafter at various time points. Formation of HSF1 trimers was detected 20 min after the heat shock in both N2a and ScN2a cells (Fig. 5A, lane 2). However, whereas in N2a cells HSF1 trimers were still present 60 min after the heat shock, they had already been disassembled in ScN2a cells at this time point (Fig. 5A, lane 4). In the presence of geldanamycin, disassembly of HSF1 trimers was significantly delayed, and the kinetics of HSE binding activity were now essentially the same in N2a and ScN2a cells. In both cell types, HSF1 trimers were present for at least 3 h after heat shock (Fig. 5B, lane 6). Of note, the relative amount of HSF1 trimers in ScN2a cells after a heat shock was not increased by geldanamycin (Fig. 5C). As a control, we analyzed the DNA binding activity of the transcription factor AP1 and did not observe qualitative or quantitative differences between N2a and ScN2a cells (data not shown).


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 5.   Geldanamycin delays HSF1 trimer disassembly. A, N2a and ScN2a cells were subjected to 44 °C for 20 min (hs +), returned to 37 °C, and harvested at the time points indicated (min after heat shock) by shock freezing in liquid nitrogen. Protein extracts were prepared and probed for HSE binding activity by electrophoretic mobility shift assays. B, N2a and ScN2a cells were incubated with geldanamycin (5 µM, 3 h) (GA + and hs -) or subjected to a heat shock (44 °C, 20 min) 2 h after administration of geldanamycin (GA +, hs +). The cells were harvested and analyzed for HSF1 trimer formation as described for A. The time points are always indicated as hours after geldanamycin treatment. As an example, in the case of co-treatment with geldanamycin and heat shock (GA + and hs +) the 3 h time point (3 h after geldanamycin) was harvested 1 h after the heat shock. C, quantitative evaluation of HSF1 trimer formation in N2a and ScN2a cells measured as HSE binding activity after a heat shock in absence and in presence of geldanamycin. The relative amount of HSF1 trimers present 20 min after the heat shock was set as 100%.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Induced expression of stress proteins provides a powerful defense mechanism to ensure cellular survival after environmental and physiological stress conditions. HSF1, the transcription factor that mediates the stress response is known; however, some aspects of its regulation remain to be elucidated. The studies reported here indicate that the defective stress response in scrapie-infected neuroblastoma (ScN2a) cells is due to an impairment of HSF1 function and can be restored by the Hsp90-binding drug geldanamycin.

Geldanamycin Corrects a Defect in HSF1 Regulation-- ScN2a cells are characterized by a defective stress-induced expression of Hsp72 and Hsp28. Inducibility of other stress-regulated Hsps as well as constitutive Hsps levels are comparable with those of uninfected N2a cells. In this study, the underlying mechanism of the impaired heat-induced expression of Hsp72 in ScN2a cells could be attributed to an impaired activation of endogenous HSF1. Upon heat treatment trimeric hyperphosphorylated HSF1 was formed in ScN2a cells; however, HSF1 trimerization and HSE binding was not sufficient to induce expression of Hsp72. Interestingly, in transfection experiments with a heat-regulated reporter construct (HSE-Luc), we observed a weak activation of the promoter. Co-transfection experiments with wtHSF1 provided a plausible explanation for this observation. Activation of HSE-Luc by overexpression of wtHSF1, which generates trimeric HSF1, was in the same range as activation by heat treatment, supporting the view that HSF1 is partially activated after stress in ScN2a cells. Activation of HSE-Luc in ScN2a cells might be due to a higher affinity of HSF1 trimers to the transfected HSE-Luc promoter or to a high copy number of HSE-Luc plasmids present after transient transfection. Notably, a constitutively active mutant of HSF1 (Delta HSF) very efficiently induced expression of Hsp72, showing that the endogenous Hsp72 gene in ScN2a cells has a functional promoter. This is in contrast to some cell lines described earlier (20, 64-66) in which a chromatin-mediated effect accounted for an impaired Hsp72 expression after stress (67, 68). Based on the finding that in ScN2a cells HSF1 activity after stress was sufficient to induce trimer formation yet insufficient to promote transactivation competence, we directed our attention to the activation/deactivation pathway of HSF1.

Initial in vitro studies established a physical interaction between Hsp90 and HSF1 (69, 70). More recently, Hsp90 was shown to act as a repressor of HSF1 trimerization in an in vitro HeLa cell extract system (27) and in the Xenopus oocyte model system (26, 28). To modulate Hsp90 function in ScN2a cells we used geldanamycin that has been described previously to promote formation of HSF1 trimers (27, 71, 72). After a short term treatment with geldanamycin, heat-induced expression of Hsp72 was restored in a subpopulation of ScN2a cells. This recovery was paralleled by a striking change in the subcellular distribution of Hsp90. Whereas in N2a cells Hsp90 was distributed homogenously in the cytosol, in ScN2a cells Hsp90 was found predominantly in aggresome-like structures, which disappeared after geldanamycin treatment. These findings suggest a deregulation of Hsp90 function in ScN2a cells. Further support for a dysfunction of Hsp90 in ScN2a cells was provided by the analysis of another Hsp90-regulated pathway, the activation of the glucocorticoid receptor. In contrast to N2a cells, dexamethasone-induced activation of the glucocorticoid receptor was significantly suppressed in ScN2a cells.

The functional HSE binding assay indicated a possible molecular basis for the effect of geldanamycin on the heat-induced expression of Hsp72. Whereas in both N2a and ScN2a cells HSF1 gained DNA binding competence rapidly after a heat shock, HSF1 trimer disassembly occurred much faster in ScN2a cells. In presence of geldanamycin, however, trimer disassembly was delayed, and the kinetics of HSF1 trimer disassembly were now very similar in N2a and ScN2a cells. Notably, the relative amount of HSF1 trimers formed after a heat shock in ScN2a cells was not enhanced by geldanamycin.

Implications for the Stress Response-- The study described above is, to our knowledge, the first demonstration that a defective heat shock response can be restored in vivo by a specific modulator of Hsp90 function. It is important to note that Hsp72 expression was absent in ScN2a cells under all heat shock conditions tested as well as under other stressful conditions causing proteotoxic damage such as oxidative stress and exposure to sodium arsenite or amino acid analogs. Thus, the deregulation of HSF1 activity in ScN2a cells could not be compensated simply by increasing the severity of the stress. Our findings support previous reports indicating that Hsp90 is a key regulator of HSF1 activity and provide new insights into the stress-regulated expression of chaperones.

Two different models of how geldanamycin modulates regulation of HSF1 activity in ScN2a cells are supported by our results (Fig. 6). It has been suggested previously that the activated HSF1 complex resembles steroid receptor complexes and that HSF1 activity is regulated similarly to steroid receptors (70). In a recent report Bharadwaj et al. (28) supported this hypothesis by showing that different constituents of the Hsp90 chaperone complex such as p23 and FKBP52 participate in the regulation of HSF1 activity in Xenopus oocytes. Thus, it is conceivable that HSF1 trimers in ScN2a cells lack transactivation competence because the HSF1-Hsp90 chaperone complex has a different composition. Binding of geldanamycin to the HSF1-Hsp90 chaperone complex might induce dissociation of regulators from this complex that suppress the transcriptional competence of trimeric HSF1. Alternatively, formation of HSF1 trimers after stress might be qualitatively the same in both cell lines, but the faster deactivation of HSF1 trimers in ScN2a cells interferes with transactivation competence. The fact that geldanamycin did not increase the relative amount of HSF1 trimers in ScN2a cells after stress but rather prolonged their lifetime might favor the kinetic model. The results obtained in transfection experiments with wtHSF1 are in line with both models discussed above. Overexpression of wtHSF1 could have provided a sufficient amount of trimeric HSF1 to compensate for the accelerated deactivation of HSF1 trimers in ScN2a cells. Alternatively, excessive HSF1 might absorb negative regulators, thereby shifting the equilibrium toward the transactivation competent form of HSF1. In summary, our data support a pivotal role of Hsp90 or a Hsp90 chaperone complex in the regulation of HSF1 activity (Fig. 6) and emphasize that the deactivation of HSF1 may play an important role in regulating Hsp72 expression.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6.   Modulation of the heat shock response in ScN2a cells by geldanamycin. The scheme depicts the three stage model of the stress-induced activation of HSF1. Without geldanamycin it appeared that trimeric HSF1 (complex II) was formed in heat-shocked ScN2a cells; however, transition into complex III with transactivation competence was impaired. Formation of complex III in geldanamycin-treated ScN2a cells can be explained by two different models. In A, the rapid deactivation of complex II and/or III is prevented by geldanamycin. Equally plausible is model B, where transition from complex II to complex III is stimulated by geldanamycin. In both models the effect of geldanamycin could relate to the inactivation of a negative regulator or to the activation of a positive factor. Possibly, geldanamycin releases a factor from the Hsp90 chaperone complex that might be degraded (negative regulator) or might then be available for activation of HSF1. Different colors of HSF1 represent the different stages of activation. ×, Hsp90 chaperone complex; GA, geldanamycin. The HSF1 complexes might differ in terms of components present in the complex or in terms of intramolecular modifications of HSF1-like phosphorylation.


    ACKNOWLEDGEMENTS

We are grateful to F. Ulrich Hartl for stimulating discussions and continuous support. We thank William J. Welch for providing the anti-Hsp72 antibody C92, Richard I. Morimoto for the DNA probe specific for Hsp72 mRNA, and Theo Rein for the GRE-Luc plasmid.

    FOOTNOTES

* This work was supported by Grant TA 167/2 from the Deutsche Forschungsgemeinschaft.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Cellular Biochemistry, Max-Planck-Institut für Biochemie, D-82152 Martinsried, Germany. E-mail: tatzelt@biochem.mpg.de.

Published, JBC Papers in Press, September 26, 2001, DOI 10.1074/jbc.M104873200

    ABBREVIATIONS

The abbreviations used are: Hsp, heat shock protein; HSF, heat shock transcription factor; HSE, heat shock element; PK, proteinase K; PBS, phosphate-buffered saline; wt, wild type; PrPC, cellular prion protein; PrPSc, scrapie prion protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Lindquist, S., and Craig, E. A. (1988) Annu. Rev. Genet. 22, 631-677
2. Hartl, F. U. (1996) Nature 381, 571-579
3. Rutherford, S. L., and Zuker, C. S. (1994) Cell 79, 1129-1132
4. Gottesman, S., Wickner, S., and Maurizi, M. R. (1997) Genes Dev. 11, 815-823
5. Bukau, B., and Horwich, A. L. (1998) Cell 92, 351-366
6. Morimoto, R. I., Jurivich, D. A., Kroeger, P. E., Marthur, S. K., Murphy, S. P., Nakai, A., Sarge, K., Abravaya, K., and Sisitonen, L. T. (1994) in The biology of heat shock proteins and molecular chaperones (Morimoto, R. I. , Tissieres, A. , and Georgopoulos, C., eds) , pp. 417-455, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
7. Buzzard, K. A., Giaccia, A. J., Killender, M., and Anderson, R. L. (1998) J. Biol. Chem. 273, 17147-17153
8. Jaattela, M., Wissing, D., Kokholm, K., Kallunki, T., and Egeblad, M. (1998) EMBO J. 17, 6124-6134
9. Mosser, D. D., Caron, A. W., Bourget, L., Denis-Larose, C., and Massie, B. (1997) Mol. Cell. Biol. 17, 5317-5327
10. Parsell, D. A., and Lindquist, S. (1994) in The Biology of Heat Shock Proteins and Molecular Chaperones (Morimoto, R. I. , Tissieres, A. , and Georgopoulos, C., eds) , pp. 457-494, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
11. Sharp, F. R., Massa, S. M., and Swanson, R. A. (1999) Trends Neurosci. 22, 97-99
12. Yenari, M. A., Giffard, R. G., Sapolsky, R. M., and Steinberg, G. K. (1999) Mol. Med. Today 5, 525-531
13. Heydari, A. R., Takahashi, R., Gutsmann, A., You, S., and Richardson, A. (1994) Experientia 50, 1092-1098
14. Gabai, V. L., Meriin, A. B., Mosser, D. D., Caron, A. W., Rits, S., Shifrin, V. I., and Sherman, M. Y. (1997) J. Biol. Chem. 272, 18033-18037
15. Baler, R., Welch, W. J., and Voellmy, R. (1992) J. Cell Biol. 117, 1151-1159
16. Wu, C. (1995) Annu. Rev. Cell Dev. Biol. 11, 441-469
17. Morimoto, R. I., Kroeger, P. E., and Cotto, J. J. (1996) Exs 77, 139-163
18. Morimoto, R. I. (1998) Genes Dev. 12, 3788-3796
19. Voellmy, R. (1996) Exs 77, 121-137
20. Hensold, J. O., Hunt, C. R., Calderwood, S. K., Housman, D. E., and Kingston, R. E. (1990) Mol. Cell. Biol. 10, 1600-1608
21. Price, B. D., and Calderwood, S. K. (1991) Mol. Cell. Biol. 11, 3365-3368
22. Jurivich, D. A., Sistonen, L., Kroes, R. A., and Morimoto, R. I. (1992) Science 255, 1243-1245
23. Bruce, J. L., Price, B. D., Coleman, C. N., and Calderwood, S. K. (1993) Cancer Res. 53, 12-15
24. Zuo, J., Rungger, D., and Voellmy, R. (1995) Mol. Cell. Biol. 15, 4319-4330
25. Cotto, J. J., Kline, M., and Morimoto, R. I. (1996) J. Biol. Chem. 271, 3355-3358
26. Ali, A., Bharadwaj, S., O'Carroll, R., and Ovsenek, N. (1998) Mol. Cell. Biol. 18, 4949-4960
27. Zou, J., Guo, Y., Guettouche, T., Smith, D. F., and Voellmy, R. (1998) Cell 94, 471-480
28. Bharadwaj, S., Ali, A., and Ovsenek, N. (1999) Mol. Cell. Biol. 19, 8033-8041
29. Zuo, J., Baler, R., Dahl, G., and Voellmy, R. (1994) Mol. Cell. Biol. 14, 7557-7568
30. Green, M., Schuetz, T. J., Sullivan, E. K., and Kingston, R. E. (1995) Mol. Cell. Biol. 15, 3354-3362
31. Duina, A. A., Kalton, H. M., and Gaber, R. F. (1998) J. Biol. Chem. 273, 18974-18978
32. Shi, Y., Mosser, D. D., and Morimoto, R. I. (1998) Genes Dev. 12, 654-666
33. Chang, N. T., Huang, L. E., and Liu, A. Y. (1993) J. Biol. Chem. 268, 1436-1439
34. Erdos, G., and Lee, Y. J. (1994) Biochem. Biophys. Res. Commun. 202, 476-483
35. Xia, W., and Voellmy, R. (1997) J. Biol. Chem. 272, 4094-4102
36. Xia, W., Guo, Y., Vilaboa, N., Zuo, J., and Voellmy, R. (1998) J. Biol. Chem. 273, 8749-8755
37. Kline, M. P., and Morimoto, R. I. (1997) Mol. Cell. Biol. 17, 2107-2115
38. Knauf, U., Newton, E. M., Kyriakis, J., and Kingston, R. E. (1996) Genes Dev. 10, 2782-2793
39. Tatzelt, J., Zuo, J. R., Voellmy, R., Scott, M., Hartl, U., Prusiner, S. B., and Welch, W. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2944-2948
40. Voellmy, R., Ahmed, A., Schiller, P., Bromley, P., and Rungger, D. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 4949-4953
41. Rosenhagen, M. C., Young, J. C., Wochnik, G. M., Herr, A. S., Schmidt, U., Hartl, F. U., Holsboer, F., and Rein, T. (2001) Biol. Chem. 382, 499-504
42. Winklhofer, K. F., and Tatzelt, J. (2000) Biol. Chem. 381, 463-469
43. Welch, W. J., and Suhan, J. P. (1986) J. Cell Biol. 103, 2035-2052
44. Tatzelt, J., Prusiner, S. B., and Welch, W. J. (1996a) EMBO J. 15, 6363-6373
45. Hunt, C., and Morimoto, R. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 6455-6459
46. Baler, R., Dahl, G., and Voellmy, R. (1993) Mol. Cell. Biol. 13, 2486-2496
47. Goldenberg, C. J., Luo, Y., Fenna, M., Baler, R., Weinmann, R., and Voellmy, R. (1988) J. Biol. Chem. 263, 19734-19739
48. Borchelt, D. R., Taraboulos, A., and Prusiner, S. B. (1992) J. Biol. Chem. 267, 16188-16199
49. Butler, D. A., Scott, M. R. D., Bockman, J. M., Borchelt, D. R., Taraboulos, A., Hsiao, K. K., Kingsbury, D. T., and Prusiner, S. B. (1988) J. Virol. 62, 1558-1564
50. Caughey, B., and Raymond, G. J. (1991a) J. Biol. Chem. 266, 18217-18223
51. Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., and Neckers, L. M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8324-8328
52. Schulte, T. W., Blagosklonny, M. V., Ingui, C., and Neckers, L. (1995) J. Biol. Chem. 270, 24585-24588
53. Smith, D. F., Whitesell, L., Nair, S. C., Chen, S., Prapapanich, V., and Rimerman, R. A. (1995) Mol. Cell. Biol. 15, 6804-6812
54. Blagosklonny, M. V., Toretsky, J., Bohen, S., and Neckers, L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8379-8383
55. Chavany, C., Mimnaugh, E., Miller, P., Bitton, R., Nguyen, P., Trepel, J., Whitesell, L., Schnur, R., Moyer, J., and Neckers, L. (1996) J. Biol. Chem. 271, 4974-4977
56. Schneider, C., Sepp-Lorenzino, L., Nimmesgern, E., Ouerfelli, O., Danishefsky, S., Rosen, N., and Hartl, F. U. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14536-14541
57. Whitesell, L., and Cook, P. (1996) Mol. Endocrinol. 10, 705-712
58. Grenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H. J., Schulte, T. W., Sausville, E., Neckers, L. M., and Toft, D. O. (1997) J. Biol. Chem. 272, 23843-23850
59. Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., and Pearl, L. H. (1997) Cell 90, 65-75
60. McIlwrath, A. J., Brunton, V. G., and Brown, R. (1996) Cancer Chemother. Pharmacol. 37, 423-428
61. Scheibel, T., and Buchner, J. (1998) Biochem. Pharmacol. 56, 675-682
62. Morano, K. A., Santoro, N., Koch, K. A., and Thiele, D. J. (1999) Mol. Cell. Biol. 19, 402-411
63. Kim, H. R., Lee, C. H., Choi, Y. H., Kang, H. S., and Kim, H. D. (1999) IUBMB Life 48, 425-428
64. Marini, A. M., Kozuka, M., Lipsky, R. H., and Nowak, T. S., Jr. (1990) J. Neurochem. 54, 1509-1516
65. Nishimura, R. N., Dwyer, B. E., Clegg, K., Cole, R., and de Vellis, J. (1991) Brain Res. Mol. Brain Res. 9, 39-45
66. Beck, S. C., Paidas, C. N., Tan, H., Yang, J., and De Maio, A. (1995) Am. J. Physiol. 269, R608-R613
67. Mathur, S. K., Sistonen, L., Brown, I. R., Murphy, S. P., Sarge, K. D., and Morimoto, R. I. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8695-8699
68. Drujan, D., and De Maio, A. (1999) Shock 12, 443-448
69. Nadeau, K., Das, A., and Walsh, C. T. (1993) J. Biol. Chem. 268, 1479-1487
70. Nair, S. C., Toran, E. J., Rimerman, R. A., Hjermstad, S., Smithgall, T. E., and Smith, D. F. (1996) Cell Stress Chaperones 1, 237-250
71. Hegde, R. S., Zuo, J., Voellmy, R., and Welch, W. J. (1995) J. Cell. Physiol. 165, 186-200
72. Kim, H. R., Kang, H. S., and Kim, H. D. (1999) IUBMB Life 48, 429-433


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Zoubeidi, A. Zardan, E. Beraldi, L. Fazli, R. Sowery, P. Rennie, C. Nelson, and M. Gleave
Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity
Cancer Res., November 1, 2007; 67(21): 10455 - 10465.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
V. Poulaki, E. Iliaki, N. Mitsiades, C. S. Mitsiades, Y. N. Paulus, D. V. Bula, E. S. Gragoudas, and J. W. Miller
Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis
FASEB J, July 1, 2007; 21(9): 2113 - 2123.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al.
Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling
J. Neurosci., February 21, 2007; 27(8): 1868 - 1878.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. K. McCollum, C. J. TenEyck, B. M. Sauer, D. O. Toft, and C. Erlichman
Up-regulation of Heat Shock Protein 27 Induces Resistance to 17-Allylamino-Demethoxygeldanamycin through a Glutathione-Mediated Mechanism.
Cancer Res., November 15, 2006; 66(22): 10967 - 10975.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-Y. Shen, J.-C. He, Y. Wang, Q.-Y. Huang, and J.-F. Chen
Geldanamycin Induces Heat Shock Protein 70 and Protects against MPTP-induced Dopaminergic Neurotoxicity in Mice
J. Biol. Chem., December 2, 2005; 280(48): 39962 - 39969.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
U. Bertsch, K. F. Winklhofer, T. Hirschberger, J. Bieschke, P. Weber, F. U. Hartl, P. Tavan, J. Tatzelt, H. A. Kretzschmar, and A. Giese
Systematic Identification of Antiprion Drugs by High-Throughput Screening Based on Scanning for Intensely Fluorescent Targets
J. Virol., June 15, 2005; 79(12): 7785 - 7791.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kiachopoulos, A. Bracher, K. F. Winklhofer, and J. Tatzelt
Pathogenic Mutations Located in the Hydrophobic Core of the Prion Protein Interfere with Folding and Attachment of the Glycosylphosphatidylinositol Anchor
J. Biol. Chem., March 11, 2005; 280(10): 9320 - 9329.
[Abstract] [Full Text] [PDF]